US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist
  • 3.100
  • +0.010+0.32%
Close Jan 17 16:00 ET
  • 3.100
  • 0.0000.00%
Post 19:58 ET
282.65MMarket Cap-6.83P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
4.15%13.54M
51.79%20.1M
8.25%12.05M
6.09%50.58M
23.63%13.21M
13.43%13M
-0.18%13.24M
-9.26%11.13M
-6.20%47.68M
-3.57%10.68M
Operating revenue
4.15%13.54M
51.79%20.1M
8.25%12.05M
6.09%50.58M
23.63%13.21M
13.43%13M
-0.18%13.24M
-9.26%11.13M
-6.20%47.68M
-3.57%10.68M
Cost of revenue
-7.52%4.44M
-31.60%4.53M
-7.35%4.39M
7.45%20.83M
-11.80%4.68M
3.74%4.8M
26.23%6.62M
12.41%4.74M
29.33%19.39M
57.61%5.31M
Gross profit
10.98%9.11M
135.10%15.57M
19.81%7.66M
5.15%29.75M
58.58%8.53M
19.98%8.2M
-17.44%6.62M
-20.59%6.4M
-21.06%28.29M
-30.28%5.38M
Operating expense
64.40%17.4M
43.25%15.52M
51.07%16.62M
-36.25%44.85M
-22.70%12.44M
-32.57%10.58M
-47.88%10.83M
-38.17%11M
-0.23%70.36M
-16.98%16.09M
Selling and administrative expenses
64.20%12.13M
54.29%11.36M
43.38%10.69M
-39.96%31.75M
-19.15%9.55M
-40.73%7.39M
-52.78%7.36M
-42.75%7.46M
-1.11%52.88M
-21.15%11.81M
Research and development costs
64.86%5.27M
19.84%4.16M
67.24%5.93M
-25.04%13.1M
-32.49%2.89M
-1.11%3.2M
-33.19%3.47M
-25.69%3.55M
2.55%17.48M
-2.77%4.28M
Operating profit
-248.76%-8.29M
101.31%55K
-94.51%-8.96M
64.10%-15.1M
63.49%-3.91M
73.15%-2.38M
67.02%-4.21M
52.71%-4.61M
-21.30%-42.07M
8.19%-10.71M
Net non-operating interest income expense
-1,693.56%-3.22M
-115.55%-2.8M
-129.72%-3.87M
171.77%8.86M
-87.31%-3.07M
105.48%202K
63.31%-1.3M
474.10%13.03M
43.99%-12.34M
52.55%-1.64M
Non-operating interest income
-35.34%979K
981.40%1.4M
-97.73%329K
16,385.86%16.32M
153.85%165K
30,180.00%1.51M
303.13%129K
--14.51M
-76.60%99K
-51.85%65K
Non-operating interest expense
219.97%4.2M
193.77%4.2M
182.45%4.2M
-40.03%7.46M
89.85%3.24M
-64.43%1.31M
-60.02%1.43M
-57.29%1.49M
-44.60%12.44M
-52.52%1.7M
Other net income (expense)
-1.38M
-1.03M
-353K
Special income (charges)
--0
--0
--0
---1.38M
---1.03M
--0
--0
---353K
--0
--0
-Less:Other special charges
----
----
----
--1.38M
--1.03M
----
----
--353K
----
----
Income before tax
-429.15%-11.51M
50.16%-2.75M
-259.00%-12.83M
85.99%-7.63M
35.15%-8.01M
82.65%-2.18M
66.21%-5.51M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
Income tax
0
0
0
245K
101K
-140K
284K
0
0
0
Net income
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
Net income continuous Operations
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
Minority interest income
Net income attributable to the parent company
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
22.87%-54.41M
57.33%-12.35M
Basic earnings per share
-333.33%-0.13
70.00%-0.03
-213.33%-0.17
88.39%-0.13
41.71%-0.1341
86.96%-0.03
72.22%-0.1
146.88%0.15
39.46%-1.12
68.06%-0.23
Diluted earnings per share
-333.33%-0.13
70.00%-0.03
-254.55%-0.17
88.39%-0.13
41.71%-0.1341
86.96%-0.03
72.22%-0.1
134.38%0.11
39.46%-1.12
68.06%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 4.15%13.54M51.79%20.1M8.25%12.05M6.09%50.58M23.63%13.21M13.43%13M-0.18%13.24M-9.26%11.13M-6.20%47.68M-3.57%10.68M
Operating revenue 4.15%13.54M51.79%20.1M8.25%12.05M6.09%50.58M23.63%13.21M13.43%13M-0.18%13.24M-9.26%11.13M-6.20%47.68M-3.57%10.68M
Cost of revenue -7.52%4.44M-31.60%4.53M-7.35%4.39M7.45%20.83M-11.80%4.68M3.74%4.8M26.23%6.62M12.41%4.74M29.33%19.39M57.61%5.31M
Gross profit 10.98%9.11M135.10%15.57M19.81%7.66M5.15%29.75M58.58%8.53M19.98%8.2M-17.44%6.62M-20.59%6.4M-21.06%28.29M-30.28%5.38M
Operating expense 64.40%17.4M43.25%15.52M51.07%16.62M-36.25%44.85M-22.70%12.44M-32.57%10.58M-47.88%10.83M-38.17%11M-0.23%70.36M-16.98%16.09M
Selling and administrative expenses 64.20%12.13M54.29%11.36M43.38%10.69M-39.96%31.75M-19.15%9.55M-40.73%7.39M-52.78%7.36M-42.75%7.46M-1.11%52.88M-21.15%11.81M
Research and development costs 64.86%5.27M19.84%4.16M67.24%5.93M-25.04%13.1M-32.49%2.89M-1.11%3.2M-33.19%3.47M-25.69%3.55M2.55%17.48M-2.77%4.28M
Operating profit -248.76%-8.29M101.31%55K-94.51%-8.96M64.10%-15.1M63.49%-3.91M73.15%-2.38M67.02%-4.21M52.71%-4.61M-21.30%-42.07M8.19%-10.71M
Net non-operating interest income expense -1,693.56%-3.22M-115.55%-2.8M-129.72%-3.87M171.77%8.86M-87.31%-3.07M105.48%202K63.31%-1.3M474.10%13.03M43.99%-12.34M52.55%-1.64M
Non-operating interest income -35.34%979K981.40%1.4M-97.73%329K16,385.86%16.32M153.85%165K30,180.00%1.51M303.13%129K--14.51M-76.60%99K-51.85%65K
Non-operating interest expense 219.97%4.2M193.77%4.2M182.45%4.2M-40.03%7.46M89.85%3.24M-64.43%1.31M-60.02%1.43M-57.29%1.49M-44.60%12.44M-52.52%1.7M
Other net income (expense) -1.38M-1.03M-353K
Special income (charges) --0--0--0---1.38M---1.03M--0--0---353K--0--0
-Less:Other special charges --------------1.38M--1.03M----------353K--------
Income before tax -429.15%-11.51M50.16%-2.75M-259.00%-12.83M85.99%-7.63M35.15%-8.01M82.65%-2.18M66.21%-5.51M161.03%8.07M22.87%-54.41M57.33%-12.35M
Income tax 000245K101K-140K284K000
Net income -465.55%-11.51M52.61%-2.75M-259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M
Net income continuous Operations -465.55%-11.51M52.61%-2.75M-259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M
Minority interest income
Net income attributable to the parent company -465.55%-11.51M52.61%-2.75M-259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -465.55%-11.51M52.61%-2.75M-259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M22.87%-54.41M57.33%-12.35M
Basic earnings per share -333.33%-0.1370.00%-0.03-213.33%-0.1788.39%-0.1341.71%-0.134186.96%-0.0372.22%-0.1146.88%0.1539.46%-1.1268.06%-0.23
Diluted earnings per share -333.33%-0.1370.00%-0.03-254.55%-0.1788.39%-0.1341.71%-0.134186.96%-0.0372.22%-0.1134.38%0.1139.46%-1.1268.06%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+8.80%
MicroStrategy
MSTR
+8.04%
Coinbase
COIN
+4.92%
Tesla
TSLA
+3.06%
Amazon
AMZN
+2.39%

Unlock the Full List